American Century Companies Inc. Purchases 654,350 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

American Century Companies Inc. grew its position in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 562.3% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 770,729 shares of the construction company’s stock after buying an additional 654,350 shares during the quarter. American Century Companies Inc. owned 1.01% of Aspen Aerogels worth $18,382,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of ASPN. Banque Cantonale Vaudoise lifted its position in shares of Aspen Aerogels by 37.5% during the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after buying an additional 1,252 shares in the last quarter. nVerses Capital LLC bought a new position in shares of Aspen Aerogels during the 2nd quarter worth approximately $95,000. NorthCrest Asset Manangement LLC bought a new position in shares of Aspen Aerogels during the 2nd quarter worth approximately $217,000. Victory Capital Management Inc. bought a new position in shares of Aspen Aerogels during the 2nd quarter worth approximately $230,000. Finally, Virtu Financial LLC bought a new position in shares of Aspen Aerogels during the 1st quarter worth approximately $246,000. Institutional investors own 97.64% of the company’s stock.

Insider Activity

In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 4.30% of the company’s stock.

Aspen Aerogels Stock Down 4.5 %

Aspen Aerogels stock opened at $27.46 on Friday. Aspen Aerogels, Inc. has a 1-year low of $6.26 and a 1-year high of $33.15. The firm has a market capitalization of $2.09 billion, a price-to-earnings ratio of -62.41 and a beta of 2.16. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23. The firm has a 50 day simple moving average of $24.90 and a 200 day simple moving average of $23.20.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings results on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.16. The firm had revenue of $117.80 million during the quarter, compared to analyst estimates of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The business’s revenue for the quarter was up 144.4% on a year-over-year basis. During the same period in the previous year, the business earned ($0.22) EPS. On average, analysts predict that Aspen Aerogels, Inc. will post 0.21 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on ASPN. B. Riley upgraded shares of Aspen Aerogels to a “strong-buy” rating in a research note on Tuesday, June 25th. TD Cowen raised their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. Craig Hallum raised their price target on shares of Aspen Aerogels from $33.00 to $38.00 and gave the stock a “buy” rating in a research note on Friday, June 14th. HC Wainwright raised their price target on shares of Aspen Aerogels from $25.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. Finally, Roth Mkm restated a “buy” rating and set a $36.00 price target on shares of Aspen Aerogels in a research note on Wednesday, August 21st. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Aspen Aerogels has an average rating of “Moderate Buy” and an average target price of $29.70.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.